Risedronate Side Effects
How can Risedronate Side Effects affect You? | PatientsVille.com
View and Submit Risedronate Side Effects
Your Risedronate Side Effect submission can play a very important role. Reporting your experience could help identify an unknown risk and inform other patients and health care professionals.
Record and Track Your Side Effects
It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.
Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Side Effects reported to FDA: 268. View Risedronate Adverse Reports
Risedronate safety alerts: 2007
Reported deaths: 13
Reported hospitalizations: 160
Bisphosphonates marketed as Alendronate (Fosamax, Fosamax Plus D), Etidronate (Didronel), Ibandronate (Boniva), Pamidronate (Aredia), Risedronate (Actonel, Actonel W/Calcium), Tiludronate (Skelid), and Zoledronic acid (Reclast, Zometa)
Audience: Geriatricians, gynecologists, orthopedic surgeons, other healthcare professionals, consumers
[Posted 10/01/2007] FDA issued an early communication about the ongoing review of new safety data regarding the association of atrial fibrillation with the use of bisphosphonates. Bisphosphonates are a class of drugs used primarily to increase bone mass and reduce the risk for fracture in patients with osteoporosis, slow bone turnover in patients with Pagetā??s disease of the bone, treat bone metastases, and lower elevated levels of blood calcium in patients with cancer.
FDA reviewed spontaneous postmarketing reports of atrial fibrillation reported in association with oral and intravenous bisphosphonates and did not identify a population of bisphosphonate users at increased risk of atrial fibrillation. In addition, as part of the data review for the recent approval of once-yearly Reclast for the treatment of postmenopausal osteoporosis, FDA evaluated the possible association between atrial fibrillation and the use of Reclast. Most cases of atrial fibrillation occurred more than a month after drug infusion. Also, in a subset of patients monitored by electrocardiogram up to the 11th day following infusion, there was no significant difference in the prevalence of atrial fibrillation between patients who received Reclast and patients who received placebo.
Upon initial review, it is unclear how these data on serious atrial fibrillation should be interpreted. Therefore, FDA does not believe that healthcare providers or patients should change either their prescribing practices or their use of bisphosphonates at this time.
[October 2007 - Early Communication - FDA]
Did You Have a Risedronate Side Effect?
How Effective is Risedronate for You?
Risedronate Adverse Reactions
Femur Fracture ( 39 Reports)|Fall ( 17 Reports)|Aspartate Aminotransferase Increased ( 16 Reports)|Osteomyelitis ( 16 Reports)|Pathological Fracture ( 16 Reports)|Alanine Aminotransferase Increased ( 15 Reports)|Condition Aggravated ( 15 Reports)|Arthralgia ( 14 Reports)|Pyrexia ( 14 Reports)|Malaise ( 12 Reports)|Pain In Extremity ( 12 Reports)|Blood Alkaline Phosphatase Increased ( 11 Reports)|Osteonecrosis ( 11 Reports)|Pain ( 10 Reports)|Stress Fracture ( 10 Reports)|Dyspnoea ( 9 Reports)|Hepatic Function Abnormal ( 9 Reports)|Leukopenia ( 9 Reports)|White Blood Cell Count Decreased ( 9 Reports)|Blood Lactate Dehydrogenase Increased ( 8 Reports)|C-reactive Protein Increased ( 8 Reports)|Decreased Appetite ( 8 Reports)|Haemoglobin Decreased ( 8 Reports)|Liver Disorder ( 8 Reports)|Pain In Jaw ( 8 Reports)|Cardiac Failure ( 7 Reports)|Cerebral Infarction ( 7 Reports)|Chest Pain ( 7 Reports)|Gait Disturbance ( 7 Reports)|Blood Bilirubin Increased ( 6 Reports)|